Clinical importance of estrogen receptor beta isoforms in breast cancer

Valerie Speirs, Andrew R Green, Thomas A Hughes, Ian O Ellis, Philippa T K Saunders, Abeer M Shaaban

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)5825; author reply 5825-6
JournalJournal of Clinical Oncology
Volume26
Issue number35
DOIs
Publication statusPublished - 10 Dec 2008

Keywords

  • Biomarkers, Tumor
  • Breast Neoplasms
  • Drug Resistance, Neoplasm
  • Estrogen Receptor Modulators
  • Estrogen Receptor beta
  • Female
  • Humans
  • Immunohistochemistry
  • Predictive Value of Tests
  • Protein Isoforms
  • Reproducibility of Results
  • Treatment Outcome
  • Comment
  • Letter

Cite this

Speirs, V., Green, A. R., Hughes, T. A., Ellis, I. O., Saunders, P. T. K., & Shaaban, A. M. (2008). Clinical importance of estrogen receptor beta isoforms in breast cancer. Journal of Clinical Oncology, 26(35), 5825; author reply 5825-6. https://doi.org/10.1200/JCO.2008.19.5909

Clinical importance of estrogen receptor beta isoforms in breast cancer. / Speirs, Valerie; Green, Andrew R; Hughes, Thomas A; Ellis, Ian O; Saunders, Philippa T K; Shaaban, Abeer M.

In: Journal of Clinical Oncology, Vol. 26, No. 35, 10.12.2008, p. 5825; author reply 5825-6.

Research output: Contribution to journalArticle

Speirs, V, Green, AR, Hughes, TA, Ellis, IO, Saunders, PTK & Shaaban, AM 2008, 'Clinical importance of estrogen receptor beta isoforms in breast cancer', Journal of Clinical Oncology, vol. 26, no. 35, pp. 5825; author reply 5825-6. https://doi.org/10.1200/JCO.2008.19.5909
Speirs V, Green AR, Hughes TA, Ellis IO, Saunders PTK, Shaaban AM. Clinical importance of estrogen receptor beta isoforms in breast cancer. Journal of Clinical Oncology. 2008 Dec 10;26(35):5825; author reply 5825-6. https://doi.org/10.1200/JCO.2008.19.5909
Speirs, Valerie ; Green, Andrew R ; Hughes, Thomas A ; Ellis, Ian O ; Saunders, Philippa T K ; Shaaban, Abeer M. / Clinical importance of estrogen receptor beta isoforms in breast cancer. In: Journal of Clinical Oncology. 2008 ; Vol. 26, No. 35. pp. 5825; author reply 5825-6.
@article{cdb03ce2a7144ff8b18d39c2d2dab8ad,
title = "Clinical importance of estrogen receptor beta isoforms in breast cancer",
keywords = "Biomarkers, Tumor, Breast Neoplasms, Drug Resistance, Neoplasm, Estrogen Receptor Modulators, Estrogen Receptor beta, Female, Humans, Immunohistochemistry, Predictive Value of Tests, Protein Isoforms, Reproducibility of Results, Treatment Outcome, Comment, Letter",
author = "Valerie Speirs and Green, {Andrew R} and Hughes, {Thomas A} and Ellis, {Ian O} and Saunders, {Philippa T K} and Shaaban, {Abeer M}",
year = "2008",
month = "12",
day = "10",
doi = "10.1200/JCO.2008.19.5909",
language = "English",
volume = "26",
pages = "5825; author reply 5825--6",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "35",

}

TY - JOUR

T1 - Clinical importance of estrogen receptor beta isoforms in breast cancer

AU - Speirs, Valerie

AU - Green, Andrew R

AU - Hughes, Thomas A

AU - Ellis, Ian O

AU - Saunders, Philippa T K

AU - Shaaban, Abeer M

PY - 2008/12/10

Y1 - 2008/12/10

KW - Biomarkers, Tumor

KW - Breast Neoplasms

KW - Drug Resistance, Neoplasm

KW - Estrogen Receptor Modulators

KW - Estrogen Receptor beta

KW - Female

KW - Humans

KW - Immunohistochemistry

KW - Predictive Value of Tests

KW - Protein Isoforms

KW - Reproducibility of Results

KW - Treatment Outcome

KW - Comment

KW - Letter

U2 - 10.1200/JCO.2008.19.5909

DO - 10.1200/JCO.2008.19.5909

M3 - Article

VL - 26

SP - 5825; author reply 5825-6

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 35

ER -